Results 101 to 110 of about 56,100 (193)

CIK细胞治疗对鼻咽癌患者肿瘤标志物及生活质量的影响

Zhongshan Daxue xuebao. Yixue kexue ban, 2011
【目的】观察鼻咽癌患者回输自体CIK细胞后临床症状缓解情况及EB病毒指标变化【方法】 收集鼻咽癌病例42例,其中放化疗联合CIK组21例进行CIK生物治疗(参照美国斯坦福大学骨髓移植中心建立的 CIK细胞培养方法诱导扩增 CIK细胞, CIK细胞培养 14 d后分次回输给患者)及进行放疗或/和化疗,放化疗组21例仅进行放疗或/和化疗【结果】随访6 ~ 27个月,中位随访时间14.5个月,放化疗联合CIK组食欲明显改善,并且其肿瘤标志物(VCA-IgAEA-IgAEA-IgG及EBV-DNA ...
doaj  

Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. [PDF]

Cell Commun Signal
Lee IT, Wang YL, Hong JH, Huang CY, Vo TTT, Lee WJ, Chiang CH.   +6 more
europepmc   +1 more source

Efficacy of modified dendritic cell-cytokine-induced killer cells loaded with tumour stem cell membrane microparticle therapy in the treatment of relapsed or refractory T- and NK-cell lymphoid proliferations and lymphomas: a report of three cases. [PDF]

Ann Hematol
Wang A, Fan T, Zhang J, Ye M, Huang H, Gao ZL.   +5 more
europepmc   +1 more source

Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges. [PDF]

Cancer Immunol Immunother
Luo Q, Jiang W, Xie Y, Dai Z, Zhu J, Du Y, Tao X, Lei Z, Chu X, Wang B, Fu G.   +10 more
europepmc   +1 more source

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial. [PDF]

Cancer Immunol Immunother
Shin H, Park Y, Song BG, Choi WM, Han HJ, Lee Y, Song TJ, Yeon JE, Lim YS, Hur MH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Lee JH, Yoon JH, Lee JH.   +16 more
europepmc   +1 more source

Therapeutic Potential of CAR-CIK Cells in Acute Leukemia Relapsed Post Allogeneic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Canichella M, de Fabritiis P, Abruzzese E.   +2 more
europepmc   +1 more source

Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. [PDF]

Sci Rep
Li S, Qin J, Sun Q, Zhao H, Xiong Y, Wang Y, Han Y, Zhang J, Zhang W, Shen M, Yang F, Ren B, Zhou L, Li R, Hui Z, Tian X, Cao S, Du W, Yu W, Liu L, Zhang X, Ren X.   +21 more
europepmc   +1 more source

Synergistic antitumor efficacy of CIK cells combined with PD-1 inhibitors in nasopharyngeal carcinoma. [PDF]

Am J Transl Res
Chen J, Sailihan T, Chen Y, Xv S, Qian J, Shen X, Yang H, Zhang P.   +7 more
europepmc   +1 more source

U ZNAKU ZAVIČAJA - U POVODU NAGRADE "FRAN GALOVIĆ" ZDRAVKU SELEŠU [PDF]

, 2015
Mihaela Cik
core   +1 more source

CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy. [PDF]

Front Oncol
Chen P, Pan J, Chen L, Feng X.
europepmc   +1 more source